Palpitation other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
An electrophysiology study (EPS) is used as a diagnostic tool in patients presenting with palpitations associated with serious symptoms such as syncope or presyncope. It is often used when other studies have proven to be | An [[electrophysiology study]] (EPS) is used as a [[diagnostic tool]] in patients presenting with [[palpitations]] associated with serious [[symptoms]] such as [[syncope]] or [[presyncope]]. It is often used when other studies have proven to be [[non-diagnostic]]. | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
| Line 10: | Line 10: | ||
===Electrophysiology study (EPS)=== | ===Electrophysiology study (EPS)=== | ||
*An electrophysiology study (EPS) is used as a diagnostic tool in patients presenting with palpitations associated with serious symptoms such as syncope or presyncope. | *An [[electrophysiology study]] (EPS) is used as a [[diagnostic tool]] in patients presenting with [[palpitations]] associated with serious [[symptoms]] such as [[syncope]] or [[presyncope]]. | ||
*It is often used when other studies have proven to be non-diagnostic. | *It is often used when other studies have proven to be [[non-diagnostic]]. | ||
*Advantages of EPS include: | *Advantages of [[EPS]] include: | ||
*#It helps identify the mechanism of the underlying arrythmia. <ref name="pmid28613787">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume= | issue= | pages= | pmid=28613787 | doi= | pmc= | url= }} </ref> | *#It helps identify the [[mechanism]] of the underlying [[arrythmia]]. <ref name="pmid28613787">{{cite journal| author=| title=StatPearls | journal= | year= 2020 | volume= | issue= | pages= | pmid=28613787 | doi= | pmc= | url= }} </ref> | ||
*#It has the potential to be both a diagnostic and therapeutic tool. <ref name="pmid31256490">{{cite journal| author=McLellan AJ, Kalman JM| title=Approach to palpitations. | journal=Aust J Gen Pract | year= 2019 | volume= 48 | issue= 4 | pages= 204-209 | pmid=31256490 | doi=10.31128/AJGP-12-17-4436 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31256490 }} </ref> | *#It has the potential to be both a [[diagnostic]] and [[therapeutic tool]]. <ref name="pmid31256490">{{cite journal| author=McLellan AJ, Kalman JM| title=Approach to palpitations. | journal=Aust J Gen Pract | year= 2019 | volume= 48 | issue= 4 | pages= 204-209 | pmid=31256490 | doi=10.31128/AJGP-12-17-4436 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31256490 }} </ref> | ||
*#Unlike ambulatory ECG monitoring, it does not cause the patient to wait for another episode, thereby decreasing the risk of the patient experiencing deleterious symptoms. | *#Unlike [[ambulatory ECG monitoring]], it does not cause the patient to wait for another episode, thereby decreasing the risk of the patient experiencing [[deleterious symptoms]]. | ||
*Disadvantages of EPS include | *Disadvantages of [[EPS]] include | ||
*#Invasive procedure | *#[[Invasive procedure]] | ||
*#Increased risk of damage to the AV Node due to ablation. <ref name="pmid21697315">{{cite journal| author=Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L | display-authors=etal| title=Management of patients with palpitations: a position paper from the European Heart Rhythm Association. | journal=Europace | year= 2011 | volume= 13 | issue= 7 | pages= 920-34 | pmid=21697315 | doi=10.1093/europace/eur130 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21697315 }} </ref> | *#Increased risk of damage to the [[AV Node]] due to [[ablation]]. <ref name="pmid21697315">{{cite journal| author=Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L | display-authors=etal| title=Management of patients with palpitations: a position paper from the European Heart Rhythm Association. | journal=Europace | year= 2011 | volume= 13 | issue= 7 | pages= 920-34 | pmid=21697315 | doi=10.1093/europace/eur130 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21697315 }} </ref> | ||
==References== | ==References== | ||
Revision as of 08:48, 16 August 2020
|
Palpitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Palpitation other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Palpitation other diagnostic studies |
|
Risk calculators and risk factors for Palpitation other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akash Daswaney, M.B.B.S[2]
Overview
An electrophysiology study (EPS) is used as a diagnostic tool in patients presenting with palpitations associated with serious symptoms such as syncope or presyncope. It is often used when other studies have proven to be non-diagnostic.
Other Diagnostic Studies
Electrophysiology study (EPS)
- An electrophysiology study (EPS) is used as a diagnostic tool in patients presenting with palpitations associated with serious symptoms such as syncope or presyncope.
- It is often used when other studies have proven to be non-diagnostic.
- Advantages of EPS include:
- It helps identify the mechanism of the underlying arrythmia. [1]
- It has the potential to be both a diagnostic and therapeutic tool. [2]
- Unlike ambulatory ECG monitoring, it does not cause the patient to wait for another episode, thereby decreasing the risk of the patient experiencing deleterious symptoms.
- Disadvantages of EPS include
- Invasive procedure
- Increased risk of damage to the AV Node due to ablation. [3]
References
- ↑ "StatPearls". 2020. PMID 28613787.
- ↑ McLellan AJ, Kalman JM (2019). "Approach to palpitations". Aust J Gen Pract. 48 (4): 204–209. doi:10.31128/AJGP-12-17-4436. PMID 31256490.
- ↑ Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L; et al. (2011). "Management of patients with palpitations: a position paper from the European Heart Rhythm Association". Europace. 13 (7): 920–34. doi:10.1093/europace/eur130. PMID 21697315.